MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.40
-0.03 (-2.10%)
As of May 16, 2:15 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,935.7% upside
Low Target $17.57
Average Target $28.50
High Target $41.49
Current Price $1.40
Current
$1.40
Target
$28.50
$17.57 $28.50 avg $41.49
Scenario Analysis
Bear Case
$17.57
1,155.0%
Low target
Base Case
$28.50
+1,935.7%
Avg target
Bull Case
$41.49
+2,863.6%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$1.96
-28.6% from high
52-Week Low
$1.17
+19.9% from low
Target vs 52W High
$28.50
+1,354.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%